Interesting facts
Interesting Facts about 2-[8,22-dihydroxy-13-(2-hydroxy-1-methyl-propyl)-2,5,11,14,27,30,33,36,39-nonaoxo-34-sec-butyl-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetic acid
This remarkable compound presents a fascinating case study in organic chemistry due to its complex molecular structure and unique properties. Here are some intriguing facts about it:
- Structural Complexity: The compound consists of a highly intricate framework, featuring multiple functional groups and a series of fused ring systems. This complexity underscores the creativity involved in modern synthetic organic chemistry.
- Therapeutic Potential: Compounds of this nature often exhibit significant biological activity. Researchers are particularly interested in exploring their potential applications in pharmaceuticals, especially in areas such as anti-cancer drugs or anti-inflammatory agents.
- Hydroxy Groups: The presence of several hydroxy groups enhances the compound's potential for forming hydrogen bonds, which can greatly influence its solubility and interaction with biological systems.
- Synthetic Challenges: The synthesis of such a compound poses considerable challenges, often requiring numerous reaction steps, specialized reagents, and conditions tailored to induce the desired transformations.
- Environmental Impact: Understanding the environmental footprint of the synthesis and degradation products derived from this compound is crucial. Chemists aim to develop greener synthetic routes that minimize waste and energy consumption.
In summary, 2-[8,22-dihydroxy-13-(2-hydroxy-1-methyl-propyl)-...acetic acid serves as a profound reminder of the intricate interplay of structure and function in chemistry, inviting students and scientists alike to delve deeper into the realms of chemical research and discovery. Its potential applications could pave the way for future advancements in medicinal chemistry.
Synonyms
epsilon-Amanitin
21705-02-2
2-[34-butan-2-yl-8,22-dihydroxy-13-(3-hydroxybutan-2-yl)-2,5,11,14,27,30,33,36,39-nonaoxo-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetic acid
alpha-Amanitin, 1-L-aspartic acid-3-((S)-4-hydroxy-L-isoleucine)-
alpha-Amanitin, 1-L-aspartic acid-3-(4-hydroxy-L-isoleucine)-, (S)-
9,18-(Iminoethaniminoethaniminoethaniminomethano)pyrrolo(1',2':8,9)(1,5,8,11,14)thiatetraazacyclooctadecino(18,17-b)indole-6-acetic acid, 1,2,3,5,6,7,8,9,10,12,17,18,19,20,21,22,23,23a-octadecahydro-29-sec-butyl-2,14-dihydroxy-21-(2-hydroxy-1-methylpropyl)-5,8,20,23,24,27,30,33-octaoxo-, 11-oxide
Cyclo(L-alpha-aspartyl-4-hydroxy-L-prolyl-(S)-4-hydroxy-L-isoleucyl-6-hydroxy-2-mercapto-L-tryptophylglycyl-L-isoleucylglycyl-L-cysteinyl), cyclic (4-8)-sulfide, (R)-8-oxide
e-Amantin
2-((1R,4S,8R,10S,13S,16S,34S)-34-((2S)-butan-2-yl)-2,8,11,14,22,30,33,36,39-nonahydroxy-13-((2R,3S)-3-hydroxybutan-2-yl)-5,27-dioxo-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonaazapentacyclo(14.12.11.06,10.018,26.019,24)nonatriaconta-2,11,14,18(26),19(24),20,22,29,32,35,38-undecaen-4-yl)acetic acid
2-(34-butan-2-yl-8,22-dihydroxy-13-(3-hydroxybutan-2-yl)-2,5,11,14,27,30,33,36,39-nonaoxo-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonazapentacyclo(14.12.11.06,10.018,26.019,24)nonatriaconta-18(26),19(24),20,22-tetraen-4-yl)acetic acid
2-[(1R,4S,8R,10S,13S,16S,34S)-34-[(2S)-butan-2-yl]-2,8,11,14,22,30,33,36,39-nonahydroxy-13-[(2R,3S)-3-hydroxybutan-2-yl]-5,27-dioxo-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonaazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-2,11,14,18(26),19(24),20,22,29,32,35,38-undecaen-4-yl]acetic acid
RefChem:137411
orb1691158
SCHEMBL29365556
DTXSID201028142
AKOS040757381
DA-59377
NS00124014
2-[34-butan-2-yl-8,22-dihydroxy-13-(3-hydroxybutan-2-yl)-2,5,11,14,27,30,33,36,39-nonaoxo-27|E4-thia-3,6,12,15,25,29,32,35,38-nonazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetic acid
Solubility of 2-[8,22-dihydroxy-13-(2-hydroxy-1-methyl-propyl)-2,5,11,14,27,30,33,36,39-nonaoxo-34-sec-butyl-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetic acid
The solubility of this complex compound is a topic of great interest due to its multifaceted structure. Here are some key points regarding its solubility characteristics:
However, due to the intricate nature of this compound, its solubility is likely to vary and may require thorough experimental investigation to fully elucidate its behavior in different solvents. As is often the case with such elaborate molecular architectures, the interplay between polar and non-polar elements within the compound will ultimately dictate its solubility profile.